All Posts
Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.
Published: February 27th, 2015
Pharmacometabolomics reveals racial differences in response to atenolol treatment.
Published: February 27th, 2015
Genomic association analysis of common variants influencing antihypertensive response to hydrochlorothiazide.
Published: February 27th, 2015
Atenolol induced HDL-C change in the pharmacogenomic evaluation of antihypertensive responses (PEAR) study.
Published: February 27th, 2015
PROX1 gene variant is associated with fasting glucose change after antihypertensive treatment.
Published: February 27th, 2015
Gene-centric meta-analysis in 87,736 individuals of European ancestry identifies multiple blood-pressure-related loci.
Published: February 27th, 2015
Hydrochlorothiazide-induced hyperuricaemia in the pharmacogenomic evaluation of antihypertensive responses study.
Published: February 27th, 2015
Is diabetes mellitus-linked amino acid signature associated with β-blocker-induced impaired fasting glucose?
Published: February 27th, 2015
Transethnic meta-analysis suggests genetic variation in the HEME pathway influences potassium response in patients treated with hydrochlorothiazide.
Published: February 27th, 2015
Baseline predictors of central aortic blood pressure: a PEAR substudy.
Published: February 27th, 2015